Quality of life in patients with urticaria

Allergy and Asthma Proceedings

Volumn 27, Issue 2, 2006, Pages 96-99

  Weldon, David R ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; CONFERENCE PAPER; COST OF ILLNESS; HEALTH SURVEY; HUMAN; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; URTICARIA;

CHRONIC DISEASE; COST OF ILLNESS; HEALTH SURVEYS; HUMANS; QUALITY OF LIFE; URTICARIA;

EID: 33646468555     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Sheldon J, Matthews K, and Lovell R. The vexing problem: Present concepts of etiology and management. J Allergy 25:525-560, 1954.
2. O'Donnell BF, Lawlor F, Simpson J, et al. The impact of chronic urticaria on the quality of life. Br J Dermatol 136:197-201, 1997.
3. Roberts G, Hurley C, and Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease. J Allergy Clin Immunol 111:491-497, 2003.
4. Goetz D, Jacobson JM, Murnane JE, et al. Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine. J Allergy Clin Immunol 84:316-322, 1989.
5. Vuurman EF, van Veggel LM, Uiterwijk MM, et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 71:121-126, 1993.
6. Weiler JM, Bloomfield JR, and Woodworth GG. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance-A randomized, placebo controlled trial in the Iowa driving stimulator. Ann Intern Med 132:354-363, 2000.
7. Pagel J. Medications and their effects on sleep. Prim Care 32: 491-509, 2005.
8. Di Lorenzo G, Pacor ML, Mansueto P, et al. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 114: 619-625, 2004.
9. Moldofsky H, Scarisbrick P, England R, and Smythe H. Musculoskeletal symptoms and non-REM sleep disturbances in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 37:341-351, 1975.
10. Roth T, and Roerhs T. Insomnia: Epidemiology, characteristics, and consequences. Clin Cornerstone 5:5-15, 2003.
11. George M, Freedman TG, Norfleet AL, et al. Qualitative research-enhanced understanding of patients' beliefs: Results of focus groups with low-income, urban, African American adults with asthma. J Allergy Clin Immunol 111:967-973, 2003.
12. Ellis CN, Drake LA, Prendergrast MM, et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 46:361-370, 2002.
13. Hyland ME. A brief guide to the selection of quality of life instrument. Health Qual Life Outcomes 1: 24, 2003.
14. Grob JJ, Revuz J, Ortonne JP, et al. Comparative study of the impact of chronic urticaria, psoriasis, and atopic dermatitis on the quality of life. Br J Dermatol 152: 289-295, 2005.
15. Baiardini I, Giardini A, Paquali M, et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy 58: 621-623, 2003.
16. Lennox RD, and Leahy MJ. Validation of the dermatology life quality index as an outcome measure for urticaria-related quality of life. Ann Allergy Asthma Immunol 93:142-146, 2004.
17. Poon E, Seed PT, Greaves MW, and Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 140:667-671, 1999.
18. Finlay AY. Measures of the effect of adult severe atopic eczema on quality of life. J Eur Acad Dermatol 7:149-154, 1996.
19. Darsow U, Ripphof E, and Ring J. Differences in itch perception between atopic eczema and chronic urticaria. J Allergy Clin Immunol 113S:S296, 2004.
20. Baiardini I, Pasquali M, Braido, F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: Chronic urticaria quality of life questionnaire (CU-QoL). Allergy 60:1073-1078, 2005.
21. Finn A, Kaplan AP, Fretwell RF, et al. A double-blind, placebo controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 104:1071-1078, 1999.
22. Grob JJ, Stalder JF, Dreyfus I, et al. Desloratadine improves quality of life and measures of impaired sleep and daily activity in chronic idiopathic urticaria. J Allergy Clin Immunol 113S:S15, 2004.
23. Monroe E, Finn A, Patel P, et al. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 48:535-541, 2003.
24. Ware JEJ, Snow KK, Kosinski M, and Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Lincoln, RI: Quality Metric, Inc., 1993.